KraneShares MSCI All China Health Care Index UCITS ETF
KURE.L
London Stock Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Ireland
- IPO Date
- Jan 14, 2021
- Similar Companies
- Business
- KraneShares MSCI All China Health Care Index UCITS ETF (KURE.L) is an exchange-traded fund that seeks to track the performance of the MSCI China All Shares Health Care 10/40 Index, which measures the equity market performance of large- and mid-cap Chinese companies engaged in the health care sector; the index applies a 10/40 rule limiting any single constituent to 10% weight and the aggregate of issuers above 5% to 40%. The ETF employs full physical replication by holding all index constituents, including key holdings such as WuXi Biologics (Cayman) Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., BeiGene Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., and CSPC Pharmaceutical Group Ltd.; it is accumulating, reinvesting dividends, with a total expense ratio of 0.65% p.a. and currency unhedged in USD. Domiciled in Ireland as an Irish Collective Asset-management Vehicle (ICAV) and launched on January 14, 2021, the ETF lists on the London Stock Exchange, Borsa Italiana, and XETRA, with assets under management of approximately EUR 1 million and geographic focus on China (over 89% exposure), supplemented by Cayman Islands and Hong Kong listings. KraneShares, the fund provider established in 2013 and headquartered in New York, USA, with a European presence including a London office opened in 2019 and operations via KraneShares ICAV in Dublin, Ireland, specializes in China-focused ETFs targeting institutions and financial professionals. The ETF operates within the health care industry segment, providing long-only exposure to pharmaceuticals, biotechnology, medical devices, and health care services across mainland China, Hong Kong, and overseas listings. Recent developments include administrative changes effective October 1, 2024, with the registered addresses of the administrator (SEI Investments – Global Fund Services Limited) and depositary (SEI Investments – Depositary and Custodial Services (Ireland) Limited) updated within Ireland; additionally, KraneShares ICAV launched new sub-funds such as the KraneShares MSCI China Clean Technology Index UCITS ETF and KraneShares ICBCCS S&P China 500 UCITS ETF in October 2023, alongside a merger of the Luxembourg-domiciled ICBCCS S&P China 500 UCITS ETF into the Irish version. No specific acquisitions, funding rounds, or product launches directly pertain to KURE.L in the past 1-2 years, though KraneShares continues expanding its UCITS-compliant China equity offerings amid broader firm initiatives in climate and alternative assets.